- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT06932263
Dosintervall Hitta studie för att bedöma effektivitet och säkerhet för Tozorakimab hos vuxna med okontrollerad astma på medel till hög dos inhalerade kortikosteroider (Umbriel)
En fas IIB, multicentre, dubbelblind, placebokontrollerad dosintervall för att hitta studie för att bedöma effektivitet och säkerhet för Tozorakimab hos vuxna deltagare med okontrollerad astma på medel till hög dos inhalerade kortikosteroider
This is a dose-range finding, double-blind, placebo-controlled, phase IIb study designed to assess efficacy and safety of tozorakimab administered subcutaneously in adult participants with uncontrolled asthma receiving medium-to-high dose inhaled corticosteroids.
Studieöversikt
Status
Betingelser
Intervention / Behandling
Studietyp
Inskrivning (Beräknad)
Fas
- Fas 2
Kontakter och platser
Studiekontakt
- Namn: AstraZeneca Clinical Study Information Center
- Telefonnummer: 1-877-240-9479
- E-post: information.center@astrazeneca.com
Studieorter
-
-
-
CABA, Argentina, C1425BEN
- Rekrytering
- Research Site
-
Ciudad de Buenos Aires, Argentina, 1128
- Indragen
- Research Site
-
Ciudad de Buenos Aires, Argentina, 1425
- Rekrytering
- Research Site
-
La Plata, Argentina, B1900
- Rekrytering
- Research Site
-
Mendoza, Argentina, 5500
- Rekrytering
- Research Site
-
Rosario, Argentina, 2000
- Rekrytering
- Research Site
-
San Miguel de Tucumán, Argentina, 4000
- Rekrytering
- Research Site
-
-
-
-
-
Caxias do Sul, Brasilien, 95070-560
- Indragen
- Research Site
-
Criciúma, Brasilien, 88811-000
- Rekrytering
- Research Site
-
Porto Alegre, Brasilien, 91350-200
- Rekrytering
- Research Site
-
Porto Alegre, Brasilien, 90610-001
- Rekrytering
- Research Site
-
Salvador, Brasilien, 40050 410
- Indragen
- Research Site
-
Santo André, Brasilien, 09080-110
- Indragen
- Research Site
-
Sorocaba, Brasilien, 18040-425
- Rekrytering
- Research Site
-
São José do Rio Preto, Brasilien, 15090-000
- Rekrytering
- Research Site
-
São Paulo, Brasilien, 05403-000
- Rekrytering
- Research Site
-
São Paulo, Brasilien, 04014-002
- Rekrytering
- Research Site
-
-
-
-
-
Curicó, Chile, 3341643
- Aktiv, inte rekryterande
- Research Site
-
Quillota, Chile, 2260000
- Aktiv, inte rekryterande
- Research Site
-
Santiago, Chile, 7500657
- Aktiv, inte rekryterande
- Research Site
-
Santiago, Chile, 7501126
- Aktiv, inte rekryterande
- Research Site
-
Santiago, Chile, 7750495
- Aktiv, inte rekryterande
- Research Site
-
Temuco, Chile, 4810345
- Aktiv, inte rekryterande
- Research Site
-
Viña del Mar, Chile, 2540488
- Aktiv, inte rekryterande
- Research Site
-
-
-
-
-
Iloilo City, Filippinerna, 5000
- Rekrytering
- Research Site
-
Las Piñas, Filippinerna, 1742
- Indragen
- Research Site
-
Lipa, Filippinerna, 4217
- Rekrytering
- Research Site
-
Manadaluyong City, Filippinerna, 1552
- Rekrytering
- Research Site
-
Quezon City, Filippinerna, 1100
- Rekrytering
- Research Site
-
Roxas City, Filippinerna, 5800
- Indragen
- Research Site
-
-
-
-
-
Brest, Frankrike, 29200
- Rekrytering
- Research Site
-
Créteil, Frankrike, 94010
- Rekrytering
- Research Site
-
Lyon, Frankrike, 69317
- Rekrytering
- Research Site
-
Marseille, Frankrike, 13015
- Rekrytering
- Research Site
-
Pessac, Frankrike, 33604
- Rekrytering
- Research Site
-
Strasbourg, Frankrike, 67091
- Rekrytering
- Research Site
-
Suresnes, Frankrike, 92150
- Rekrytering
- Research Site
-
-
-
-
California
-
Bakersfield, California, Förenta staterna, 93301
- Rekrytering
- Research Site
-
Huntington Beach, California, Förenta staterna, 92647
- Indragen
- Research Site
-
La Mesa, California, Förenta staterna, 91942
- Avslutad
- Research Site
-
Loma Linda, California, Förenta staterna, 92354
- Indragen
- Research Site
-
Long Beach, California, Förenta staterna, 90815
- Rekrytering
- Research Site
-
Newport Beach, California, Förenta staterna, 92663
- Rekrytering
- Research Site
-
San Jose, California, Förenta staterna, 95117
- Rekrytering
- Research Site
-
-
Delaware
-
Wilmington, Delaware, Förenta staterna, 19805
- Avslutad
- Research Site
-
-
Florida
-
Cutler Bay, Florida, Förenta staterna, 33189
- Upphängd
- Research Site
-
Hialeah, Florida, Förenta staterna, 33015
- Upphängd
- Research Site
-
Leesburg, Florida, Förenta staterna, 34748
- Indragen
- Research Site
-
Miami, Florida, Förenta staterna, 33175
- Upphängd
- Research Site
-
Miami, Florida, Förenta staterna, 33155
- Upphängd
- Research Site
-
Miami Lakes, Florida, Förenta staterna, 33016
- Upphängd
- Research Site
-
Orlando, Florida, Förenta staterna, 32819
- Upphängd
- Research Site
-
Palmetto Bay, Florida, Förenta staterna, 33157
- Upphängd
- Research Site
-
Tampa, Florida, Förenta staterna, 33607
- Upphängd
- Research Site
-
Winter Park, Florida, Förenta staterna, 32789
- Upphängd
- Research Site
-
-
Idaho
-
Boise, Idaho, Förenta staterna, 83706
- Indragen
- Research Site
-
-
Indiana
-
Noblesville, Indiana, Förenta staterna, 46060
- Rekrytering
- Research Site
-
-
Iowa
-
West Des Moines, Iowa, Förenta staterna, 50266
- Avslutad
- Research Site
-
-
Kansas
-
Hutchinson, Kansas, Förenta staterna, 67502
- Rekrytering
- Research Site
-
Kansas City, Kansas, Förenta staterna, 66160
- Indragen
- Research Site
-
-
Kentucky
-
Louisville, Kentucky, Förenta staterna, 40218
- Rekrytering
- Research Site
-
-
Maryland
-
White Marsh, Maryland, Förenta staterna, 21162
- Indragen
- Research Site
-
-
Massachusetts
-
Worcester, Massachusetts, Förenta staterna, 01605
- Rekrytering
- Research Site
-
-
Michigan
-
Farmington Hills, Michigan, Förenta staterna, 48336
- Rekrytering
- Research Site
-
Warren, Michigan, Förenta staterna, 48088
- Indragen
- Research Site
-
-
Missouri
-
St Louis, Missouri, Förenta staterna, 63141
- Indragen
- Research Site
-
-
Nebraska
-
Bellevue, Nebraska, Förenta staterna, 68123
- Indragen
- Research Site
-
Grand Island, Nebraska, Förenta staterna, 68803
- Rekrytering
- Research Site
-
Omaha, Nebraska, Förenta staterna, 68134
- Rekrytering
- Research Site
-
-
New Jersey
-
Millville, New Jersey, Förenta staterna, 08332
- Har inte rekryterat ännu
- Research Site
-
Mullica Hill, New Jersey, Förenta staterna, 08062
- Rekrytering
- Research Site
-
Toms River, New Jersey, Förenta staterna, 08755
- Rekrytering
- Research Site
-
-
New York
-
Horseheads, New York, Förenta staterna, 14845
- Rekrytering
- Research Site
-
Maspeth, New York, Förenta staterna, 11378
- Rekrytering
- Research Site
-
-
North Carolina
-
Asheville, North Carolina, Förenta staterna, 28803
- Indragen
- Research Site
-
Huntersville, North Carolina, Förenta staterna, 28078
- Indragen
- Research Site
-
Kings Mountain, North Carolina, Förenta staterna, 28086
- Rekrytering
- Research Site
-
Pinehurst, North Carolina, Förenta staterna, 28374
- Indragen
- Research Site
-
-
Ohio
-
Toledo, Ohio, Förenta staterna, 43617
- Rekrytering
- Research Site
-
-
Oklahoma
-
Edmond, Oklahoma, Förenta staterna, 73034
- Indragen
- Research Site
-
-
Oregon
-
Grants Pass, Oregon, Förenta staterna, 97527
- Indragen
- Research Site
-
Medford, Oregon, Förenta staterna, 97504
- Rekrytering
- Research Site
-
Portland, Oregon, Förenta staterna, 97202
- Rekrytering
- Research Site
-
-
Pennsylvania
-
DuBois, Pennsylvania, Förenta staterna, 15801
- Avslutad
- Research Site
-
Philadelphia, Pennsylvania, Förenta staterna, 19140
- Rekrytering
- Research Site
-
Smithfield, Pennsylvania, Förenta staterna, 15478
- Rekrytering
- Research Site
-
-
South Carolina
-
Rock Hill, South Carolina, Förenta staterna, 29732
- Rekrytering
- Research Site
-
-
Tennessee
-
Knoxville, Tennessee, Förenta staterna, 37919
- Avslutad
- Research Site
-
-
Texas
-
Austin, Texas, Förenta staterna, 78759
- Rekrytering
- Research Site
-
Boerne, Texas, Förenta staterna, 78006
- Rekrytering
- Research Site
-
Dallas, Texas, Förenta staterna, 75254
- Rekrytering
- Research Site
-
El Paso, Texas, Förenta staterna, 79912
- Rekrytering
- Research Site
-
Forney, Texas, Förenta staterna, 75126
- Avslutad
- Research Site
-
Greenville, Texas, Förenta staterna, 75401
- Rekrytering
- Research Site
-
Kingwood, Texas, Förenta staterna, 77339
- Rekrytering
- Research Site
-
McKinney, Texas, Förenta staterna, 75069
- Indragen
- Research Site
-
Sugar Land, Texas, Förenta staterna, 77478
- Rekrytering
- Research Site
-
Victoria, Texas, Förenta staterna, 77901
- Rekrytering
- Research Site
-
-
Utah
-
Roy, Utah, Förenta staterna, 84067
- Avslutad
- Research Site
-
-
Washington
-
Bellingham, Washington, Förenta staterna, 98225
- Avslutad
- Research Site
-
-
West Virginia
-
Kingwood, West Virginia, Förenta staterna, 26537
- Rekrytering
- Research Site
-
-
Wisconsin
-
Milwaukee, Wisconsin, Förenta staterna, 53228
- Rekrytering
- Research Site
-
-
-
-
-
Athens, Grekland, 11521
- Aktiv, inte rekryterande
- Research Site
-
Athens, Grekland, 17562
- Aktiv, inte rekryterande
- Research Site
-
Ioannina, Grekland, 45500
- Indragen
- Research Site
-
Pátrai, Grekland, 26504
- Aktiv, inte rekryterande
- Research Site
-
Thessaloniki, Grekland, 57010
- Aktiv, inte rekryterande
- Research Site
-
Thessaloniki, Grekland, 57001
- Upphängd
- Research Site
-
-
-
-
-
Belagavi, Indien, 590010
- Rekrytering
- Research Site
-
Coimbatore, Indien, 641028
- Rekrytering
- Research Site
-
Dehradun, Indien, 248001
- Rekrytering
- Research Site
-
Delhi, Indien, 110029
- Rekrytering
- Research Site
-
Faridabad, Indien, 121012
- Indragen
- Research Site
-
Gūrgaon, Indien, 122001
- Indragen
- Research Site
-
Kochi, Indien, 682027
- Avslutad
- Research Site
-
Lucknow, Indien, 226003
- Upphängd
- Research Site
-
New Delhi, Indien, 110005
- Rekrytering
- Research Site
-
Vadodara, Indien, 391760
- Rekrytering
- Research Site
-
-
-
-
-
Haifa, Israel, 3109601
- Rekrytering
- Research Site
-
Jerusalem, Israel, 91120
- Rekrytering
- Research Site
-
Kfar Saba, Israel, 44281
- Rekrytering
- Research Site
-
Ramat Gan, Israel, 52621
- Rekrytering
- Research Site
-
Rehovot, Israel, 76100
- Rekrytering
- Research Site
-
-
-
-
-
Catania, Italien, 95123
- Rekrytering
- Research Site
-
Foggia, Italien, 71100
- Rekrytering
- Research Site
-
Genoa, Italien, 16132
- Rekrytering
- Research Site
-
Roma, Italien, 00168
- Rekrytering
- Research Site
-
-
-
-
-
Fukuoka, Japan, 811-1394
- Rekrytering
- Research Site
-
Ginowan-shi, Japan, 901-2214
- Rekrytering
- Research Site
-
Hiroshima, Japan, 730-0013
- Rekrytering
- Research Site
-
Ishinomaki, Japan, 986-8522
- Rekrytering
- Research Site
-
Kawaguchi-shi, Japan, 332-8558
- Rekrytering
- Research Site
-
Kiyose-shi, Japan, 204-8585
- Rekrytering
- Research Site
-
Kobe, Japan, 650-0017
- Rekrytering
- Research Site
-
Meguro-ku, Japan, 152-8902
- Rekrytering
- Research Site
-
Miura, Japan, 238-0111
- Rekrytering
- Research Site
-
Neyagawa, Japan, 572-8551
- Rekrytering
- Research Site
-
Sapporo, Japan, 064-0804
- Rekrytering
- Research Site
-
Sapporo, Japan, 060-0033
- Rekrytering
- Research Site
-
Takamatsu, Japan, 761-8073
- Rekrytering
- Research Site
-
Ube, Japan, 755-8505
- Rekrytering
- Research Site
-
Yokohama, Japan, 232-0066
- Rekrytering
- Research Site
-
Yokohama, Japan, 245-8575
- Rekrytering
- Research Site
-
Yokohama, Japan, 232-0024
- Rekrytering
- Research Site
-
-
-
-
-
Baotou, Kina, 014010
- Rekrytering
- Research Site
-
Changchun, Kina, 130021
- Rekrytering
- Research Site
-
Chengdu, Kina, 610000
- Rekrytering
- Research Site
-
Chongqing, Kina, 400010
- Rekrytering
- Research Site
-
Guangzhou, Kina, 510163
- Rekrytering
- Research Site
-
Haikou, Kina, 570311
- Rekrytering
- Research Site
-
Hefei, Kina, 230061
- Rekrytering
- Research Site
-
Hohhot, Kina, 10050
- Rekrytering
- Research Site
-
Huizhou, Kina, 516001
- Rekrytering
- Research Site
-
Qingdao, Kina, 266011
- Rekrytering
- Research Site
-
Shanghai, Kina, 200025
- Rekrytering
- Research Site
-
Shanghai, Kina, 200065
- Rekrytering
- Research Site
-
Shanghai, Kina, 201114
- Rekrytering
- Research Site
-
Shenzhen, Kina, 518020
- Rekrytering
- Research Site
-
Wenzhou, Kina, 325027
- Rekrytering
- Research Site
-
Xuzhou, Kina, 221000
- Rekrytering
- Research Site
-
-
-
-
-
Lima, Peru, 15046
- Aktiv, inte rekryterande
- Research Site
-
Lima, Peru, LIMA 21
- Indragen
- Research Site
-
Lima, Peru, 15088
- Aktiv, inte rekryterande
- Research Site
-
Lima, Peru, LIMA 33
- Indragen
- Research Site
-
Lima, Peru, 15082
- Aktiv, inte rekryterande
- Research Site
-
Lima, Peru, LIMA 1
- Aktiv, inte rekryterande
- Research Site
-
-
-
-
-
Barcelona, Spanien, 08003
- Rekrytering
- Research Site
-
Barcelona, Spanien, 8025
- Rekrytering
- Research Site
-
Madrid, Spanien, 28041
- Rekrytering
- Research Site
-
Málaga, Spanien, 29010
- Rekrytering
- Research Site
-
Mérida, Spanien, 06800
- Indragen
- Research Site
-
Patraix, Spanien, 46017
- Rekrytering
- Research Site
-
Santander, Spanien, 39008
- Rekrytering
- Research Site
-
-
-
-
-
Bellville, Sydafrika, 7530
- Rekrytering
- Research Site
-
Benoni, Sydafrika, 1501
- Rekrytering
- Research Site
-
Brackenfell, Sydafrika, 7560
- Rekrytering
- Research Site
-
Cape Town, Sydafrika, 7700
- Rekrytering
- Research Site
-
Durban, Sydafrika, 4093
- Rekrytering
- Research Site
-
Somerset West, Sydafrika, 7130
- Rekrytering
- Research Site
-
eMkhomazi, Sydafrika, 4170
- Rekrytering
- Research Site
-
-
-
-
-
Cheongju-si, Sydkorea, 28644
- Aktiv, inte rekryterande
- Research Site
-
Daegu, Sydkorea, 42415
- Aktiv, inte rekryterande
- Research Site
-
Seoul, Sydkorea, 03080
- Rekrytering
- Research Site
-
Seoul, Sydkorea, 03722
- Aktiv, inte rekryterande
- Research Site
-
Seoul, Sydkorea, 08308
- Aktiv, inte rekryterande
- Research Site
-
Seoul, Sydkorea, 05505
- Aktiv, inte rekryterande
- Research Site
-
Seoul, Sydkorea, 03312
- Aktiv, inte rekryterande
- Research Site
-
Seoul, Sydkorea, 06591
- Avslutad
- Research Site
-
-
-
-
-
Kaohsiung City, Taiwan, 80756
- Rekrytering
- Research Site
-
New Taipei City, Taiwan, 231
- Indragen
- Research Site
-
Taichung, Taiwan, 40705
- Rekrytering
- Research Site
-
Taichung, Taiwan, 433004
- Rekrytering
- Research Site
-
Taipei, Taiwan, 10002
- Rekrytering
- Research Site
-
Taipei, Taiwan, 11220
- Rekrytering
- Research Site
-
Taipei, Taiwan, 110
- Rekrytering
- Research Site
-
Taipei, Taiwan, 11696
- Rekrytering
- Research Site
-
-
-
-
-
Bangkok, Thailand, 10700
- Rekrytering
- Research Site
-
Chanthaburi, Thailand, 22000
- Rekrytering
- Research Site
-
Chiang Rai, Thailand, 57000
- Rekrytering
- Research Site
-
Chon Buri, Thailand, 20000
- Rekrytering
- Research Site
-
Khon Kaen, Thailand, 40002
- Rekrytering
- Research Site
-
Nakhon Sri Thammarat, Thailand, 80000
- Rekrytering
- Research Site
-
-
-
-
-
Adana, Turkiet (Türkiye), 01330
- Rekrytering
- Research Site
-
Ankara, Turkiet (Türkiye), 06280
- Rekrytering
- Research Site
-
Bursa, Turkiet (Türkiye), 16059
- Rekrytering
- Research Site
-
Gaziantep, Turkiet (Türkiye), 27470
- Rekrytering
- Research Site
-
Istanbul, Turkiet (Türkiye), 34890
- Rekrytering
- Research Site
-
Kayseri, Turkiet (Türkiye), 38039
- Rekrytering
- Research Site
-
Mersin, Turkiet (Türkiye), 33079
- Rekrytering
- Research Site
-
-
-
-
-
Balassagyarmat, Ungern, 2660
- Aktiv, inte rekryterande
- Research Site
-
Budapest, Ungern, 1121
- Indragen
- Research Site
-
Budapest, Ungern, 1036
- Indragen
- Research Site
-
Debrecen, Ungern, 4032
- Aktiv, inte rekryterande
- Research Site
-
Gödöllő, Ungern, 2100
- Aktiv, inte rekryterande
- Research Site
-
Pécs, Ungern, 7635
- Aktiv, inte rekryterande
- Research Site
-
Törökbálint, Ungern, 2045
- Aktiv, inte rekryterande
- Research Site
-
-
-
-
-
Da Nang, Vietnam, 550000
- Rekrytering
- Research Site
-
Haiphong, Vietnam, 180000
- Rekrytering
- Research Site
-
Hanoi, Vietnam, 100000
- Rekrytering
- Research Site
-
Ho Chi Minh City, Vietnam, 700000
- Rekrytering
- Research Site
-
Ho Chi Minh City, Vietnam, 700000
- Indragen
- Research Site
-
Ho Chi Minh City, Vietnam, 10000
- Rekrytering
- Research Site
-
Huế, Vietnam, 530000
- Rekrytering
- Research Site
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Beskrivning
Inclusion Criteria:
-
Provision of signed and dated written informed consent prior to any study-specific procedures.
-
Adults aged 18-75, inclusive when signing the informed consent.
-
Documented physician-diagnosis of asthma for at least 12 months.
-
Treated with medium or high dose ICS in combination with LABA.
-
Demonstration of uncontrolled asthma through ACQ-6 score ≥ 1.5 .
-
Pre-bronchodilator FEV1 ≥ 40% to ≤ 90% of predicted normal.
-
Documented exacerbation history in the last 12 months and biomarker requirements of:
- ≥ 2 severe exacerbations OR
- 1 severe exacerbation and:
(i) Eosinophils ≥ 150 cells/µl or (ii) FeNo ≥ 25 ppb
-
Participants need to demonstrate a ≥70% compliance for Asthma Daily Diary.
-
Women of Child Bearing Potential (WOCBP) must have a negative pregnancy test.
-
Contraceptive use by males and females should be consistent with local regulations regarding the methods of contraception for those participating in clinical studies.
Exclusion Criteria:
- Completed treatment for respiratory infection with antibiotics in the 4 weeks prior to Visit 1.
- Clinically significant pulmonary disease other than asthma .
- Current smokers, former smokers with >10 pack-years history.
- Clinically significant aortic stenosis or pulmonary arterial hypertension.
- Active tuberculosis, hepatitis, HIV, or current diagnosis of cancer or immune complex disease.
- Unstable cardiovascular disorders.
Studieplan
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Behandling
- Tilldelning: Randomiserad
- Interventionsmodell: Parallellt uppdrag
- Maskning: Fyrdubbla
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
|---|---|
|
Experimentell: Tozorakimab Dose 1
Dosing subcutaneously tozorakimab Dose 1 |
The drug will be administered subcutaneously. |
|
Experimentell: Tozorakimab Dose 2
Dosing subcutaneously tozorakimab Dose 2 and placebo |
The drug will be administered subcutaneously. |
|
Placebo-jämförare: Placebo
Dosing subcutaneously with equivalent volume to tozorakimab |
Placebo will be administered subcutaneously. |
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Annualised rate of severe asthma exacerbations
Tidsram: Over 26 to 52 weeks
|
The rate ratio of severe asthma exacerbations will be assessed in the participants with uncontrolled moderate-to-severe asthma and ≥ 1 severe exacerbation within 12 months prior to screening. |
Over 26 to 52 weeks
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Annualised rate of severe asthma exacerbations
Tidsram: Over 26 to 52 weeks
|
The rate ratio of severe asthma exacerbations will be assessed in the participants with uncontrolled moderate-to-severe asthma and baseline eosinophils < 300 cells/µL and history of ≥2 severe exacerbations within 12 months prior to screening. |
Over 26 to 52 weeks
|
|
Time to first severe asthma exacerbation
Tidsram: Over 26 to 52 weeks
|
To evaluate the effect of two dose levels of tozorakimab compared to placebo on time to first severe asthma exacerbations. |
Over 26 to 52 weeks
|
|
Change from baseline in pre-bronchodilator forced expiratory volume in 1 second (FEV1)
Tidsram: Over weeks 20 to 26
|
Difference in mean change from baseline between tozorakimab and placebo. |
Over weeks 20 to 26
|
|
Change from baseline in post-bronchodilator FEV1
Tidsram: At week 26
|
Difference in mean change from baseline between tozorakimab and placebo. |
At week 26
|
|
Change from baseline in the Asthma Control Questionnaire 6 (ACQ-6)
Tidsram: At week 26
|
Difference in mean change from baseline between tozorakimab and placebo. The ACQ-6 has 6 questions (regarding asthma symptoms and rescue bronchodilator use). Answering the questions results in a score out of 6. A Score of 0 indicates complete control and 6 reflects severely uncontrolled disease. |
At week 26
|
|
Change from baseline in the Asthma Quality of Life Questionnaire for 12 Years and Older (AQLQ12+)
Tidsram: At week 26
|
Difference in mean change from baseline between tozorakimab and placebo. The AQLQ12+ includes 32 questions grouped into four domains: symptoms; activity limitations; emotional function; and, environmental stimuli. Each question is scored on a seven-point Likert scale, which ranges from 7 (no impairment) to 1 (severe impairment). The overall score is calculated as the mean of all questions, and the four domain scores are the means of the scores for the questions in the respective domains. |
At week 26
|
|
Trough serum concentrations of tozorakimab
Tidsram: Over 52 weeks
|
Pharmacokinetics: concentrations of tozorakimab in trough serum. |
Over 52 weeks
|
|
Anti-drug antibody incidence
Tidsram: Over 52 weeks
|
Immunogenicity: Number of Participants With Positive Antibodies to tozorakimab |
Over 52 weeks
|
Samarbetspartners och utredare
Sponsor
Studieavstämningsdatum
Studera stora datum
Studiestart (Faktisk)
Primärt slutförande (Beräknad)
Avslutad studie (Beräknad)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Faktisk)
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- D9181C00002
- 2024-519116-14-00 (Registeridentifierare: CTIS)
Plan för individuella deltagardata (IPD)
Planerar du att dela individuella deltagardata (IPD)?
IPD-planbeskrivning
Qualified researchers can request access to anonymized individual patient-level data from AstraZeneca group of companies sponsored clinical trials via the request portal Vivli.org. All requests will be evaluated as per the AZ disclosure commitment: https://astrazenecagrouptrials.pharmacm.com/ST/Submission/Disclosure. Yes, indicates that AZ are accepting requests for IPD, but this does not mean all requests will be shared.
Tidsram för IPD-delning
AstraZeneca will meet or exceed data availability as per the commitments made to the EFPIA PhRMA Data Sharing Principles. For details of our timelines, please rerefer to our disclosure commitment at https://astrazenecagrouptrials.pharmacm.com/ST/Submission/Disclosure.
Kriterier för IPD Sharing Access
When a request has been approved AstraZeneca will provide access to the anonymized individual patient-level data via secure research environment Vivli.org.
Signed Data Usage Agreement (non-negotiable contract for data accessors) must be in place before accessing requested information.
IPD-delning som stöder informationstyp
- STUDY_PROTOCOL
- SAV
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Studerar en amerikansk FDA-reglerad produktprodukt
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .